Display options
Share it on

Open Orthop J. 2015 Jun 26;9:218-25. doi: 10.2174/1874325001509010194. eCollection 2015.

Hybrid Biosynthetic Autograft Extender for Use in Posterior Lumbar Interbody Fusion: Safety and Clinical Effectiveness.

The open orthopaedics journal

Mokbel K Chedid, Kelly M Tundo, Jon E Block, Jeffrey M Muir

Affiliations

  1. Henry Ford Health System - West Bloomfield Michigan, 6777 West Maple Road, West Bloomfield, MI 48322, USA.
  2. The Jon Block Group, 2210 Jackson Street, Suite 401, San Francisco, CA 94115, USA.

PMID: 26161161 PMCID: PMC4493627 DOI: 10.2174/1874325001509010194

Abstract

Autologous iliac crest bone graft is the preferred option for spinal fusion, but the morbidity associated with bone harvest and the need for graft augmentation in more demanding cases necessitates combining local bone with bone substitutes. The purpose of this study was to document the clinical effectiveness and safety of a novel hybrid biosynthetic scaffold material consisting of poly(D,L-lactide-co-glycolide) (PLGA, 75:25) combined by lyophilization with unmodified high molecular weight hyaluronic acid (10-12% wt:wt) as an extender for a broad range of spinal fusion procedures. We retrospectively evaluated all patients undergoing single- and multi-level posterior lumbar interbody fusion at an academic medical center over a 3-year period. A total of 108 patients underwent 109 procedures (245 individual vertebral levels). Patient-related outcomes included pain measured on a Visual Analog Scale. Radiographic outcomes were assessed at 6 weeks, 3-6 months, and 1 year postoperatively. Radiographic fusion or progression of fusion was documented in 221 of 236 index levels (93.6%) at a mean (±SD) time to fusion of 10.2+4.1 months. Single and multi-level fusions were not associated with significantly different success rates. Mean pain scores (+SD) for all patients improved from 6.8+2.5 at baseline to 3.6+2.9 at approximately 12 months. Improvements in VAS were greatest in patients undergoing one- or two-level fusion, with patients undergoing multi-level fusion demonstrating lesser but still statistically significant improvements. Overall, stable fusion was observed in 64.8% of vertebral levels; partial fusion was demonstrated in 28.8% of vertebral levels. Only 15 of 236 levels (6.4%) were non-fused at final follow-up.

Keywords: Bone extender; hyaluronic acid; intervertebral level; local bone autograft; lumbar fusion

References

  1. J Neurosurg Spine. 2014 Jul;21(1):106-32 - PubMed
  2. Eur Spine J. 2013 May;22(5):1158-63 - PubMed
  3. Med Hypotheses. 2000 Dec;55(6):474-9 - PubMed
  4. Surg Gynecol Obstet. 1946 Feb;82:215-8 - PubMed
  5. Ann Emerg Med. 2001 Dec;38(6):633-8 - PubMed
  6. J Spinal Disord. 2001 Dec;14 (6):533-40 - PubMed
  7. J Bone Joint Surg Br. 1989 Aug;71(4):677-80 - PubMed
  8. Int Orthop. 2009 Feb;33(1):187-9 - PubMed
  9. J Neurosurg Spine. 2012 May;16(5):471-8 - PubMed
  10. Spine (Phila Pa 1976). 2006 Apr 20;31(9):985-91 - PubMed
  11. Spine (Phila Pa 1976). 2001 Mar 1;26(5):567-71 - PubMed
  12. Spine J. 2009 Nov;9(11):880-5 - PubMed
  13. World J Orthop. 2014 Jan 18;5(1):30-7 - PubMed
  14. Neurosurg Focus. 2004 Mar 15;16(3):E8 - PubMed
  15. Spine J. 2012 Dec;12(12):1122-8 - PubMed
  16. Spine (Phila Pa 1976). 2012 Jul 15;37(16):E993-1000 - PubMed
  17. J Neurosurg Sci. 2012 Sep;56(3):203-7 - PubMed
  18. J Neurosurg. 1953 Mar;10(2):154-68 - PubMed
  19. Spine (Phila Pa 1976). 1989 Dec;14(12):1324-31 - PubMed
  20. Spine (Phila Pa 1976). 2008 May 20;33(12 ):1299-304 - PubMed
  21. J Neurosurg Spine. 2012 Jan;16(1):61-7 - PubMed
  22. Tissue Eng Part A. 2011 Jan;17(1-2):213-20 - PubMed
  23. Acad Emerg Med. 2003 Oct;10(10):1128-30 - PubMed
  24. J Spinal Disord Tech. 2006 Apr;19(2):92-7 - PubMed
  25. Eur Spine J. 2011 Apr;20(4):635-9 - PubMed
  26. Clin Orthop Relat Res. 1983 Dec;(181):255-63 - PubMed
  27. Global Spine J. 2014 Aug;4(3):211-6 - PubMed
  28. J Neurosurg Spine. 2011 May;14(5):598-604 - PubMed
  29. Surgeon. 2013 Feb;11(1):39-48 - PubMed

Publication Types